SecBot SecBot
Institutional Cluster

DMAC

DiaMedica Therapeutics Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed4mo ago
Institutional cluster: 3 buyers, 1 sellers (bullish)
Actionable Insight • Neutral

The cluster is entirely passive index rebalancing — no active manager conviction signal. Monitor for any active fund 13F filings (e.g., sector-specific healthcare funds) in subsequent quarters to gauge genuine institutional interest. The Vanguard trim is notable as a partial reversal of prior accumulation.

DirectionNeutral
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d
DMAC ▲ +23.63% at T+60d
NEUTRAL call +23.63% · α vs SPY +19.23% · entry $5.46 → $6.75
Entry = T+0 close
Jun 11, 2026
via day close
T+1d
+3.48%
call +3.48% · α +2.94%
$5.65
settled 5mo ago
T+5d
+4.95%
call +4.95% · α +4.51%
$5.73
settled 4mo ago
T+20d
+41.21%
call +41.21% · α +39.32%
$7.71
settled 4mo ago
T+60d
+23.63%
call +23.63% · α +19.23%
$6.75
settled 7w ago

Executive Summary

Three mega-passive institutional investors (BlackRock, State Street, Morgan Stanley) collectively added $12.2M in DMAC during Q3 2025, while Vanguard trimmed $1.4M. The net $10.8M inflow from passive index rebalancing suggests no active fundamental thesis, consistent with the stock's small-cap pharma profile.

Key Financial Metrics

Direction
accumulating
Buy Value
$18.8M
Sell Value
$6.0M
Net Flow
$10.8M

Institutional Positions

Net institutional flow: $10.8M

▲ Buyers (3)

InstitutionActionChangePosition ValueValue Δ
BlackRockADD+40.8%$11.5M$6.9M
State StreetADD+89.2%$3.3M$2.3M
Morgan StanleyDOUBLED+141%$4.0M$3.0M

▼ Sellers (1)

InstitutionActionChangePrev ValueValue Δ
VanguardTRIM-56.7%$6.0M-$1.4M

Key Facts

  • 3 passive mega-funds added $12.2M in aggregate DMAC holdings during Q3 2025
  • BlackRock increased position by 40.8% to $11.5M, the largest buyer
  • Morgan Stanley doubled its position (+141%) to $4.0M
  • Vanguard trimmed 56.7% of its position, reducing holdings by $1.4M to $4.6M
  • All four funds are mega-passive index managers — no active hedge fund or activist involvement
  • Net institutional inflow of ~$10.8M represents ~3.8% of DMAC's $287M market cap

Financial Impact

3 passive buyers added $12.2M in new positions while 1 passive seller reduced by $1.4M, for net institutional inflow of approximately $10.8M

institutional ownershipfloat

Risk Factors

  • Passive flows are mechanical and may reverse next quarter without fundamental catalyst
  • 13F data is 45+ days stale; positions may have already been adjusted
  • Small market cap ($287M) means even modest passive flows can distort ownership percentages

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
91% bullish (11 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-DMAC-2025-Q3
5 reports for DMAC
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for DMAC — sortable, filterable
TypeNow
Aug 15, 2026
10w ago
Institutional Cluster
NEUTRAL ★ 3/10
$6.62 $6.53▼ −1.36%▲ +0.62%—
Aug 10, 2026
11w ago
8-K
BULLISH ★ 7/10
$6.87 $6.59▼ −4.08%▼ −3.02%—
Jun 11, 2026
19w ago
Institutional Cluster
NEUTRAL ★ 3/10
$5.46 $7.71▲ +41.21%▲ +39.32%—
May 6, 2026
24w ago
8-K
BEARISH ★ 6/10
$6.53 $5.65▲ +13.48%▲ +16.61%—
Apr 1, 2026
29w ago
DEFA14A
NEUTRAL ★ 3/10
$6.48 $6.05▼ −6.64%▼ −16.51%—
Showing 5 of 5

US Market Status

Market Closed — Opens in 4h 12m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 11, 2026